- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 113,690 | 27.09.24 03:00:28 | +0,600 | +0,53% | 113,200 | 113,690 | 113,170 | 113,690 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 97,370 | 27.09.24 22:44:45 | -2,010 | -2,02% | 96,200 | 107,000 | 100,380 | 97,370 |
